Cargando…
Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents
BACKGROUND: Sofosbuvir is the keystone of direct antiviral agents for the chronic hepatitis C (CHC). The safety of sofosbuvir in patients with stage 4–5 chronic kidney disease (CKD) needs further observation in real world. CASE PRESENTATION: Thirty-three patients with stage 5 CKD and hepatitis C vir...
Autores principales: | Yan, Taotao, Wang, Jiuping, Li, Juan, Fu, Shan, Chen, Yi, Hu, Chunhua, Zhang, Rou, Tian, Zhen, Zhao, Fahui, Dong, Jun, Liu, Jinfeng, Yang, Yuan, Chen, Tianyan, Zhao, Yingren, He, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588848/ https://www.ncbi.nlm.nih.gov/pubmed/31226947 http://dx.doi.org/10.1186/s12879-019-4117-x |
Ejemplares similares
-
High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy
por: Wang, Jing, et al.
Publicado: (2021) -
Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B
por: Li, Juan, et al.
Publicado: (2021) -
Incidence of mother‐to‐child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta‐analysis
por: Yao, Naijuan, et al.
Publicado: (2022) -
Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China
por: Chen, Tianyan, et al.
Publicado: (2018) -
Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression
por: Zhang, Yu, et al.
Publicado: (2016)